Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...
Karnalyte Resources Inc. ("Karnalyte" or the "Company") (TSX: KRN) is pleased to announce that the NI 43-101 Technical Report on the updated feasibility study for its Wynyard Project has been filed an ...
FCBStudios' latest addition to Birmingham's Paradise masterplan pairs bold terracotta detailing with net-zero credentials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback